| For: | Vasilev G, Kokudeva M, Siliogka E, Padilla N, Shumnalieva R, Della-Morte D, Ricordi C, Mihova A, Infante M, Velikova T. T helper 17 cells and interleukin-17 immunity in type 1 diabetes: From pathophysiology to targeted immunotherapies. World J Diabetes 2025; 16(4): 99936 [PMID: 40236846 DOI: 10.4239/wjd.v16.i4.99936] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i4/99936.htm |
| Number | Citing Articles |
| 1 |
Bidhayak Chakraborty, Sreenivasa Nayaka, Chandan A. Bhairappanavar, Gireesh Babu Kantli, Shashiraj Kariyellappa Nagaraja. Network pharmacology and molecular simulation insights into the anti-diabetic and anti-inflammatory mechanisms of Ricinus communis. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; 399(5): 7053 doi: 10.1007/s00210-025-04827-z
|
| 2 |
Roha Asif, Ammara Khalid, Tolga Mercantepe, Aleksandra Klisic, Sana Rafaqat, Saira Rafaqat, Filiz Mercantepe. Role of Interleukins in Type 1 and Type 2 Diabetes. Diagnostics 2025; 15(15): 1906 doi: 10.3390/diagnostics15151906
|
| 3 |
Eiji Kawasaki. Fulminant and Slowly Progressive Type 1 Diabetes Associated with Pregnancy. International Journal of Molecular Sciences 2025; 26(13): 6499 doi: 10.3390/ijms26136499
|
| 4 |
Eugenio Cavalli, Giuseppe Rosario Pietro Nicoletti, Ferdinando Nicoletti. A Historical and Epistemological Review of Type 1 Diabetes Mellitus. Journal of Clinical Medicine 2025; 14(14): 4923 doi: 10.3390/jcm14144923
|
| 5 |
Tinglin Lu, Weidong Qiang, Qingqing Ye. Cytokines and chemokines in diabetes: Immunopathogenesis, therapeutic targets, and future perspectives across all disease forms. Pathology - Research and Practice 2026; 282: 156466 doi: 10.1016/j.prp.2026.156466
|
